Detalles de la búsqueda
1.
Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
Prostate
; 71(12): 1344-56, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21308717
2.
Prolonged treatment with bicalutamide induces androgen receptor overexpression and androgen hypersensitivity.
Prostate
; 70(7): 745-54, 2010 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20058237
3.
Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10.
Prostate
; 70(5): 457-66, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19902465
4.
Structure-activity relationships of bioisosteric replacement of the carboxylic acid in novel androgen receptor pure antagonists.
Bioorg Med Chem
; 18(9): 3159-68, 2010 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20381361
5.
Design and synthesis of an androgen receptor pure antagonist (CH5137291) for the treatment of castration-resistant prostate cancer.
Bioorg Med Chem
; 18(23): 8150-7, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21050768
6.
CH5137291, an androgen receptor nuclear translocation-inhibiting compound, inhibits the growth of castration-resistant prostate cancer cells.
Int J Oncol
; 46(4): 1560-72, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25634071
7.
Discovery of an orally-active nonsteroidal androgen receptor pure antagonist and the structure-activity relationships of its derivatives.
Chem Pharm Bull (Tokyo)
; 56(11): 1555-61, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18981605
8.
Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists.
Bioorg Med Chem Lett
; 17(20): 5573-6, 2007 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17804229
Resultados
1 -
8
de 8
1
Próxima >
>>